Edesa Biotech, Inc. (NASDAQ:EDSA) filed a Form 8-K with the Securities and Exchange Commission on February 13, 2026, disclosing a material event.
Edesa Biotech, Inc.'s stock currently trades at $1.02 with a market capitalization of $12.3M. The Healthcare company's stock moved following the disclosure.